Methicillin-resistant Staphylococcus aureus: Emerging community dissemination;Staphylococcus aureus resistentes à meticilina: Disseminaç ão emergente na comunidade *

Anais Brasileiros de Dermatologia

Volumn 84, Issue 5, 2009, Pages 501-506

  Gelatti, Luciane Cristina ^a   Becker, Ana Paula ^a   Bonamigo, Renan Rangel ^a,b,c   D'Azevedo, Pedro Alves ^a  

^a UNIVERSIDADE FEDERAL DE CIÊNCIAS DA SAÚDE DE PORTO ALEGRE   (Brazil)

^b Sociedade Brasileira de Dermatologia   (Brazil)

^c FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Bacterial infections; Methicillin; Staphylococcus aureus

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; BACTERIAL SKIN DISEASE; BACTERIUM ISOLATE; CLONING; HUMAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NONHUMAN; REVIEW;

HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCAL INFECTIONS;

EID: 75749152604     PISSN: 03650596     EISSN: 18064841     Source Type: Journal    
DOI: 10.1590/S0365-05962009000500009     Document Type: Review

References (29)

1. Altemeier WA, Culbertson WR, Veto M. Prophylactic antibiotic therapy. AMA Arch Surg. 1955;71:2-6.
2. Barraviera B. Estudo clínico das estafilococcias. J Bras Med. 1994;67:160-92.
3. Ferreira MS, Gonçalves EG, Assis VP. Como diagnosticar e tratar infecções estafilocócicas . Rev Bras Med. 1985;42:179-89.
4. Lowy FD. Staphylococcus aureus infections. N Engl J Med. 1998;339:520-32.
5. Chambers HF. Methicillin resistance in Staphylococci: molecular and biochemical basis and clinical implications. Clin Microbiol Rev. 1997;10:781-91.
6. Bustos-Martínez JA, Hamdan-Partida A, Gutiérrez- Cárdenas M. Staphylococcus aureus: la reemergencia de un patógeno en la comunidad. Rev Biomed. 2006;17:287-305.
7. Salgado CD, Farr BM, Calfee DP. Community-acquired methicillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors. Clin Infect Dis. 2003;36:131-9.
8. Forbes BA, Sahm DF, Weissfeld AS. Staphylococcus, Micrococcus, and similar organisms. In: Forbes BA, Sahm DF, Weissfeld AS, editors. Bailey & Scott's Diagnostic Microbiology. St Louis: Mosby; 1998. p.607-18.
9. Naimi TS, LeDell KH, Como-Sabetti K, Borchardt SM, Boxrud DJ, Etienne J, et al. Comparison of community-and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA. 2003; 290: 2976-84.
10. Dufour P, Gillet Y, Bes M, Lina G, Vandenesch F, Floret D, et al. Community-acquired methicillin-resistant infections in France: emergence of a single clone that produces Panton-Valentine leukocidin. Clin Infect Dis. 2002;35:819-24.
11. Moran GJ, Krishnadasan A, Gorwitz RJ, Fosheim GE, Mcdougal LK, Carey RB, et al. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med. 2006; 355:666-74.
12. Lina G, Piemont Y, Godail-Gamot F, Bes M, Peter MO, Gauduchon V, et al. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis. 1999;29:1128-32.
13. Miller LG, Perdreau-Remington F, Rieg G, Mehdi S, Perlroth J, Bayer AS, et al. Necrotizing fasciitis caused by community-associated methicillin- resistant Staphylococcus aureus in Los Angeles. N Engl J Med. 2005;352:1445-53.
14. Gillet Y, Issartel B, Vanhems P, Fournet JC, Lina G, Bes M, et al. Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotizing pneumonia in young immunocompetent patients. Lancet. 2002;359:753-9.
15. Chambers HF. MRSA: the San Francisco experience. Program and abstracts of the 45th Interscience Conference on Antimicrobial Agents and Chemotherapy; December 16-19, 2005; Washington, DC. Abstract 1324.
16. Patel M, Waites KB, Moser SA, Cloud GA, Hoesley CJ. Prevalence of inducible clindamycin resistance among community and hospital-associated Staphylococcus aureus isolates. J Clin Microbiol. 2006;44:2481-4.
17. Ribeiro A, Dias C, Silva-Carvalho MC, Berquo L, Ferreira FA, Santos RN, et al. First report of infection with community-acquired methicillin-resistant Staphylococcus aureus in South America. J Clin Microbiol. 2005;43:1985-88.
18. Rajendran PM, Young D, Maurer T, Chambers H, Perdreau-Remington F, Ro P, et al. Randomized, double-blind, placebo-controlled trial of Cephalexin for treatment of uncomplicated skin abscesses in a population at risk for community-acquired methicillinresistant Staphylococcus aureus infection. Antimicrob Agents Chemother. 2007;51:4044-48.
19. Udo EE, Pearman JW, Grubb WB. Genetic analysis of community isolates of methicillin-resistant Staphylococcus aureus in Western Australia. J Hosp Infect. 1993; 25:97-108.
20. Centers of Disease Control and Prevention. Outbreaks of community-associated methicillin-resistant Staphylococcus aureus skin infections - Los Angeles County, California, 2002-3. MMWR Morb Mortal Wkly Rep. 2003;52:88.
21. Kazakova SV, Hageman JC, Matava M, Srinivasan A, Phelan L, Garfinkel B, et al. A clone of methicillin-resistant Staphylococcus aureus among football players. N Engl J Med. 2005; 352:468-475.
22. Ma XX, Galiana A, Pedreira W, Mowszowicz M, Chrisphersen I, Machiavello S, et al.Community-acquired methicillin-resistant Staphylococcus aureus, Uruguay. Emerg Infect Dis. 2005;11:973-976.
23. Paganini H, Della Latta MP, Opet BM, Ezcurra G, Uranga M, Aguirre C, et al. Estudio multicéntrico sobre las infecciones pediátricas por Staphylococcus aureus meticilino-resistente provenientes de la comunidad en la Argentina. Arc Argen Pediatr. 2008;106:397-403.
24. Nimmo GR, Schooneveldt J, O'Kane G, McCall B, Vickery A. Community acquisition of gentamicin-sensitive methicillin-resistant Staphylococcus aureus in Southeast Queensland, Australia. J Clin Microbiol. 2000;38:3926-31.
25. Munckhof WJ, Schooneveldt J, Coombs GW, Hoare J, Nimmo GR . Emergence of community-acquired methicillin-resistant Staphylococcus aureus (MRSA) infection in Queensland, Australia. Int Infect Dis. 2003;7:259-67.
26. Bratu S, Landmand D, Gupta J, Irehan M, Panwar M, Quale J. A population-based study examining the emergente of community-associated methicillin-resistant Staphylococcus aureus USA300 in New York City. Ann Clin Microbiol Antimicrob. 2006;5:29.
27. Huang H, Flynn NM, King JH, Monchaud C, Morita M, Cohen SH. Comparisons of community-associated methicillin resistant Staphylococcus aureus (MRSA) and hospital-associated MRSA infections in Sacramento, California. J Clin Microbiol.2006;44:2423-27.
28. Maree CL, Daum RS, Boyle-Vavra S, Matayoshi K, Miller LG. Community-associated methicillin-resistant Staphylococcus aureus isolates causing healthcareassociated infections. Emerg Infect Dis. 2007;13:236-42.
29. Ribeiro A, Coronado AZ, Silva-Carvalho MC, Ferreira-Carvalho BT, Dias C, Rozenbaum R, et al. Detection and characterization of international community-acquired infections by methicillin-resistant Staphylococcus aureus clones in Rio de Janeiro and Porto Alegre cities causing both community-and hospital-associated diseases. Diagn Microbiol Infect Dis. 2007;59:339-45.